Researchers compared milvexian with enoxaparin for the prevention of blood clots in 1,242 patients from 18 countries undergoing knee replacement surgery who were enrolled between June 2019 and February 2021. They found that at a total daily dose of 100 mg or more, milvexian resulted in bette